))
Perspectives on Leadership, Education and the Future of Clinical Care in IBS with Lin Chang, MD
Manage episode 407440329 series 3560280
Contenu fourni par Healio, Sameer K. Berry, MD, and William D. Chey. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Healio, Sameer K. Berry, MD, and William D. Chey ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In this podcast episode, Lin Chang, MD, vice-chief of Vatche and Tamar Manoukian Division of Digestive Diseases, discusses her path to GI, her interest in IBS and some of the newest therapies coming down the pipe and more.
- Intro :02
- Welcome to this episode of Gut Talk :22
- About Chang :28
- The interview :46
- Where did you grow up? :49
- Who are your early role models? 3:50
- How far along in college were you before you decided to apply for medical school? 4:58
- How did you get interested in GI? 5:32
- What advice would you give to the residents and fellows that you interact with in that regard? 8:42
- As you started your career you weren’t necessarily thinking that you were going to be a clinical/academic icon … didn’t you start mostly as a clinician? 11:56
- Early on when we started working together … you were the only woman in the room. How were you able to break through that glass ceiling and get into the room? 17:38
- What advice do you give your fellows who want to get more involved? 22:12
- How did you get interested in a condition like IBS? 24:02
- Could you explain to our listeners what it means by the biopsychosocial model when referring to IBS? 26:21
- Do you think that, in actuality, these could be completely separate diseases? 29:03
- Discussion on the layers of IBS 32:26
- Do you mind summarizing your key takeaways from an American Gastrological Association clinical practice update on the role of diet in patients with IBS? 38:03
- Another document we’re working on right now is the first joint society (AGA, ACG) clinical practice guideline on treatment of chronic constipation … would you like to say a couple words about that one? 42:04
- What does your future look like? What are you thinking is next for Lin Chang? 44:39
- In your role as program director, what are the trends that you’ve noticed amongst trainees? 46:46
- What are you most excited about with regards to the newer therapies and treatment paradigms, the new care delivery models that are on the horizon to help patients with IBS? 49:13
- Lin, this has been a great discussion 51:00
- Thanks for listening 51:37
Lin Chang, MD, is the vice-chief of Vatche and Tamar Manoukian Division of Digestive Diseases, program director of the UCLA GI Fellowship Program and the co-director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience.
We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc
Disclosures: Berry and Chey report no relevant financial disclosures. Chang reports no relevant financial disclosures.
28 episodes
Partager
